AXGN - Company ID 0000805928
The table below shows Axogen, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $61.46M | $60.08M | $56.66M | $48.56M | $48.64M | $47.91M |
| Cost of revenue | $15.27M | $14.09M | $14.64M | $13.63M | $12.21M | $12.57M |
| Gross profit | $46.19M | $45.99M | $42.02M | $34.93M | $36.44M | $35.34M |
| R&D | $7.52M | $7.57M | $6.85M | $6.09M | $7.00M | $6.66M |
Axogen, Inc. reported annual revenue of $225.21M for fiscal year 2025. That is up 20.2% from $187.34M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $41.11M (FY 2016) to $225.21M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $12.87M | $10.84M | $9.69M | $9.46M | $10.83M | $9.42M |
| Operating income | -$2.83M | $1.91M | $1.67M | -$1.66M | -$316.00K | -$428.00K |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$19.58M | $708.00K | $579.00K | -$3.83M | -$1.86M | -$1.92M |
| EPS (diluted) | -$0.38 | $0.01 | $0.01 | -$0.08 | -$0.04 | -$0.04 |